Title
City of Phoenix Naloxone Program Quarterly Report (November - January) - Citywide
Description
This report serves as an update for the Community Services and Education Subcommittee highlighting the progress of the City of Phoenix Naloxone Program's third year for quarter 2, November 2025 - January 2026.
THIS ITEM IS FOR INFORMATION ONLY.
Report
Summary
During the second quarter of programmatic year 3 (Y3Q2), the City of Phoenix Naloxone Program maintained stable, citywide naloxone access, distributing 3,181 Naloxone Overdose Reversal Kits. While this represents a 37 percent decrease compared to the previous quarter, it is a 50 percent increase compared to this same quarter in the previous programmatic year, illustrating sustained year-over-year growth. Seasonal declines during winter months are to be expected due to reduced outdoor outreach, fewer large-scale events, and decreased foot traffic coinciding with the holidays. Overall, as of Y3Q2, a total of 33,481 Naloxone Overdose Reversal Kits have been distributed since program launch in August 2023.
In Y3Q2, Libraries, Human Services, and the Office of Public Health (OPH) remained the program’s top distributors. Likewise, the Community Assistance Program increased distribution for the second quarter in a row through greater targeted outreach.
In collaboration with the Office of Homeless Solutions, a critical initiative this quarter was the expansion of naloxone access within City of Phoenix shelters. In partnership with the Arizona Department of Health Services, OPH established free-standing naloxone displays at the North Mountain Healing Center, Phoenix Navigation Center, Rio Fresco Healing Center, Safe Outdoor Space, and Washington Street Shelter in late October. Over a three-month period, 1,053 two-dose units of naloxone were distributed across these five shelters, signaling effective service delivery to high-need populations.
Overall, the Naloxone Program remains stable and aligned with anticipated seasonal distribution patterns, while continuing to mature operationally through targeted access strategies, improved data quality, and sustained geographic coverage across the City of Phoenix.
Financial Impact
There is no impact to the General Fund. The Naloxone Program is funded through the One Arizona Agreement Opioid Settlement funds. Naloxone is an approved abatement strategy and allowable expense under the agreement. Total cost in Y3Q2 was $5,537.68. In-kind donations of naloxone and related resources this quarter amounted to an estimated $79,596.
Public Outreach
OPH promoted the Naloxone Program at three outreach and community engagement events in Districts 4, 5, and 7 during this reporting period, primarily servicing individuals experiencing homelessness and, in collaboration with Strategic Initiatives, in support of human trafficking victims. Outreach efforts during this quarter emphasized smaller, targeted engagements with high-risk populations, reflecting the office’s commitment to providing services to those most in need.
Department
Responsible Department
This item is submitted by Deputy City Manager Gina Montes and the Office of Public Health.